INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 130 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2015. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93,140,241 | -18.7% | 1,788,064 | -1.1% | 0.05% | -13.0% |
| Q2 2023 | $114,497,066 | +18.0% | 1,808,229 | +0.9% | 0.05% | +10.2% |
| Q1 2023 | $97,047,039 | +2.3% | 1,792,189 | -0.1% | 0.05% | 0.0% |
| Q4 2022 | $94,909,691 | +13.5% | 1,793,456 | -0.2% | 0.05% | +6.5% |
| Q3 2022 | $83,633,000 | -13.8% | 1,797,410 | +5.7% | 0.05% | -4.2% |
| Q2 2022 | $97,020,000 | -6.7% | 1,699,730 | +0.1% | 0.05% | +14.3% |
| Q1 2022 | $103,943,000 | +82.8% | 1,698,696 | +56.3% | 0.04% | +100.0% |
| Q4 2021 | $56,877,000 | +11.8% | 1,086,682 | -20.4% | 0.02% | +10.5% |
| Q3 2021 | $50,875,000 | -8.7% | 1,364,659 | +0.0% | 0.02% | -9.5% |
| Q2 2021 | $55,705,000 | +40.5% | 1,364,652 | +16.8% | 0.02% | +31.2% |
| Q1 2021 | $39,648,000 | +396.9% | 1,168,546 | +90.1% | 0.02% | +300.0% |
| Q2 2019 | $7,979,000 | +6.6% | 614,700 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $7,487,000 | +6.9% | 614,700 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $7,001,000 | -34.6% | 614,700 | +24.7% | 0.00% | -20.0% |
| Q3 2018 | $10,700,000 | +9.0% | 493,100 | +94.9% | 0.01% | 0.0% |
| Q2 2016 | $9,821,000 | +39.6% | 253,000 | 0.0% | 0.01% | +25.0% |
| Q1 2016 | $7,033,000 | -71.1% | 253,000 | -44.0% | 0.00% | -66.7% |
| Q4 2015 | $24,308,000 | +29.9% | 451,900 | -3.3% | 0.01% | +33.3% |
| Q3 2015 | $18,719,000 | +59.8% | 467,500 | +27.5% | 0.01% | +80.0% |
| Q2 2015 | $11,716,000 | +33.8% | 366,700 | 0.0% | 0.01% | +25.0% |
| Q1 2015 | $8,757,000 | -0.6% | 366,700 | -26.5% | 0.00% | 0.0% |
| Q4 2014 | $8,806,000 | +14.7% | 498,900 | -10.9% | 0.00% | 0.0% |
| Q3 2014 | $7,675,000 | -45.0% | 559,800 | -32.4% | 0.00% | -33.3% |
| Q2 2014 | $13,962,000 | -8.6% | 828,100 | -1.5% | 0.01% | -14.3% |
| Q1 2014 | $15,277,000 | – | 840,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |